You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Revascularization

:

Citations 41-50 of 245 total displayed.

Past content (since Jun 1998):

Letters
Long-term Mortality Associated With Aprotinin Following Coronary Artery Bypass Graft Surgery
Steven G. Coca; Chirag R. Parikh
JAMA 2007; 297: 2475-a-2476-a. [Extract] [Full text] [PDF]  

Letters
Long-term Mortality Associated With Aprotinin Following Coronary Artery Bypass Graft Surgery
Elke Scharnetzky; Walter Schill; Edeltraut Garbe
JAMA 2007; 297: 2475. [Extract] [Full text] [PDF]  

Letters
Long-term Mortality Associated With Aprotinin Following Coronary Artery Bypass Graft Surgery
Robert H. Habib; Anoar Zacharias; Thomas A. Schwann
JAMA 2007; 297: 2476-a-2477-a. [Extract] [Full text] [PDF]  

Letters
Long-term Mortality Associated With Aprotinin Following Coronary Artery Bypass Graft Surgery
Jeffrey Shuhaiber
JAMA 2007; 297: 2476. [Extract] [Full text] [PDF]  

Letters
Long-term Mortality Associated With Aprotinin Following Coronary Artery Bypass Graft Surgery—Reply
Dennis T. Mangano
JAMA 2007; 297: 2477. [Extract] [Full text] [PDF]  

Original Contributions
Differences in Mortality and Use of Revascularization in Black and White Patients With Acute MI Admitted to Hospitals With and Without Revascularization Services
Ioana Popescu; Mary S. Vaughan-Sarrazin; Gary E. Rosenthal
JAMA 2007; 297: 2489-2495. [Abstract] [Full text] [PDF] [ The JAMA Report ]  

Original Contributions
Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial
Paul Erne; Andreas W. Schoenenberger; Dieter Burckhardt; Michel Zuber; Wolfgang Kiowski; Peter T. Buser; Paul Dubach; Therese J. Resink; Matthias Pfisterer
JAMA 2007; 297: 1985-1991. [Abstract] [Full text] [PDF]  

Original Contributions
Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
Nirat Beohar; Charles J. Davidson; Kevin E. Kip; Lynne Goodreau; Helen Aslanidou Vlachos; Sheridan N. Meyers; Keith H. Benzuly; James D. Flaherty; Mark J. Ricciardi; Charles L. Bennett; David O. Williams
JAMA 2007; 297: 1992-2000. [Abstract] [Full text] [PDF] [ JAMA News Video ]  

Original Contributions
Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
Htut K. Win; Angel E. Caldera; Kelly Maresh; John Lopez; Charanjit S. Rihal; Manish A. Parikh; Juan F. Granada; Sachin Marulkar; Deborah Nassif; David J. Cohen; Neal S. Kleiman; for the EVENT Registry Investigators
JAMA 2007; 297: 2001-2009. [Abstract] [Full text] [PDF]  

Editorials
The Enigma of Drug-Eluting Stents: Hope, Hype, Humility, and Advancing Patient Care
Robert A. Harrington; E. Magnus Ohman
JAMA 2007; 297: 2028-2030. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

 Collections
 •Sign up for Topic Collection Alerts
 • Show Revascularization
 collections from JAMA & Archives Journals.
 •Topic Collections Home
 •Related collections:
  •Cardiovascular Interventions
  •Revascularization
  •Pacemakers/ Defibrillators
  •Thrombolysis
  •Cardiovascular Interventions, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.